About
About Sutro
Patient Resources
Collaborations
Corporate Presentation
Leadership
Leadership Team
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Technology
XpressCF® and XpressCF+™ Platforms
Antibody-Drug Conjugates and IADCs
Bispecific and Engineered Antibodies
cGMP Facility
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Pipeline
News
News Releases
Clinical / Scientific Presentation and Publication Highlights
Events
Events Audio Replays
Careers and Culture
The Way We Work
Join Our Team
Diversity, Equity, Inclusion and Belonging
DEIB Newsletter
Internships
Sutroites
Volunteer Opportunities
Contact Us
Search
Navigation
About
About Sutro
Patient Resources
Partnerships
Corporate Presentation
Leadership
Leadership Team
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Technology
XpressCF® and XpressCF+™ Platforms
Antibody-Drug Conjugates and IADCs
Bispecific and Engineered Antibodies
cGMP Facility
Investors
Company Presentation
Stock
Financials
Governance
Contact IR
Email Alerts
Pipeline
News
News Releases
Clinical / Scientific Presentation and Publication Highlights
Events
Events Audio Replays
Careers and Culture
Join Our Team
Diversity, Equity, Inclusion and Belonging
DEIB Newsletter
Internships
Sutroites
Contact Us
Close
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
News Releases
Events & Audio Replays
Email Alerts
Company Info
Overview
Management Team
Functional Leadership Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analysts Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Filing Type:
View All
10-K
10-K/A
10-Q
3
4
424B4
424B5
8-A12B
8-K
CERT
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
POS EX
POSASR
REGDEX
REGDEX/A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-3MEF
S-8
SC 13D
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2022
2021
2020
2019
2018
2009
2007
2006
Date
Form
Description
PDF
XBRL
Pages
02/01/22
4
Statement of changes in beneficial ownership of securities
2
02/01/22
4
Statement of changes in beneficial ownership of securities
2
02/01/22
4
Statement of changes in beneficial ownership of securities
2
02/01/22
4
Statement of changes in beneficial ownership of securities
2
01/18/22
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
Documents
EX-99.1
10
01/10/22
8-K
Current report filing
Documents
EX-99.1
29
01/05/22
8-K
Current report filing
Documents
EX-99.1
EX-99.2
26
01/03/22
4
Statement of changes in beneficial ownership of securities
2
12/27/21
8-K
Current report filing
4
12/10/21
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
6
Previous
1
2
3
4
5
6
7
8
9
10
…32
Next
Email Alerts
Contacts
RSS News Feed